Target intelligence / Profile preview

T cell receptor alpha variable 20 (TRAV20)

Target
TRAV20
Molecular classification
Receptor, Immunoglobulin superfamily, Protein-coding gene
01

Overview

TRAV20 encodes the variable region of the T cell receptor alpha chain, which pairs with a beta chain to form the αβ T cell receptor expressed on T lymphocytes. This receptor is responsible for recognizing processed antigenic peptides bound to major histocompatibility complex (MHC) molecules on antigen-presenting cells. The interaction mediates antigen-specific immune responses by activating T cells through signal transduction pathways involving CD3 and other adaptor proteins, ultimately resulting in T cell proliferation, cytokine release, and effector function. The variable regions (including TRAV20) contribute to the extraordinary diversity of T cell antigen specificity by undergoing genetic recombination during T cell development. TRAV20 is classified within the immunoglobulin superfamily, as part of the receptor family of molecules, and its biological functions center on antigen recognition and immune surveillance. Variability in TRAV20, as in other TCR segments, is essential for shaping the adaptive immune response.

Other names
TRAV20TCRAV20S1TCRAV30S1TVA20
02

Mechanism of action

Drugs targeting TCR generally act by modulating antigen recognition or T cell activation, including: blocking peptide-MHC engagement; inhibiting signal transduction downstream of TCR/CD3 complex; enhancing T cell activation against tumors or pathogens.

03

Biological functions

Immune responseAntigen recognitionSignal transductionT cell adaptive immunity
04

Disease associations

CancerInfectionInflammation
05

Safety considerations

Off-target immune responses (autoimmunity)Cytokine release syndromeLoss of antigen specificity leading to immunodeficiency
06

Biomarkers

T cell repertoire profilingBiomarker in immunological researchMonitoring T cell clonal expansion in diseases (cancer, infection, autoimmunity)

Beyond the preview

Go deeper on T cell receptor alpha variable 20 (TRAV20).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor alpha variable 20 (TRAV20).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call